medicines which are substrates with the CYP3A enzyme as They might become fewer powerful for the duration of cure with JOURNAVX. Your Health care provider may have to regulate the dose of your medicine when starting off or halting JOURNAVXGiven that conolidine modulates ion channels and specified G protein-coupled receptors, prolonged use might eff